Asthma/COPD Flashcards
SABA
Albuterol
Levalbuterol
SABAs
Salmeterol Formoterol Budesonide/Formoterol Mometasone/Formoterol Fluticasone/Salmeterol Fluticasone/Vilanterol (Breo Ellipta)
LABAs
Tiotropium (Spiriva)
LAAC aka LAAM aka LAMA
DOC for long-term control of pts with any degree of persistent asthma
ICS (inhaled corticosteroids)
Sx tx of bronchospasm providing quick relief of acute bronchoconstriction; rapid onset 5-30 mins; 4-6 hour relief; monotherapy for patients with intermittent or exercise-induced asthma
SABA, albuterol and levalbuterol
Less tachycardic effects than albuterol
levalbuterol
A/E: Tachycardia, hyperglycemia, hypokalema, hypomagnesemia, B2-mediated skeletal muscle tremors
SABAs
Bronchodilation for ~12 hrs; slow onset of action
Monotherapy C/I for asthma patients
Used in conjunction with an ICS
Combination drugs now exist with an ICS (symbicort, advair, dulera, Breo Ellipta).
LABAs
Beclomethasone, Budesonide, Ciclesonide, Fluticasone, Mometasone; DOC for long-term control for pts with any degree of PERSISTENT asthma. Inhibits arachidonic acid which mediates normal inflammatory responses. Metabolism in the liver. Low bioavailability.
ICS
No direct on the airway smooth muscle
ICS
Directly targets underlying airway inflammation through daily use
ICS
IV methylprednisolone or oral prednisone needed to reduce airway inflammation during _____ exacerbations.
severe
Systemic administration of corticosteroids should be reserved for patients who are not controlled on ____.
ICS
A/E: Deposition on the oral and laryngeal mucosa can cause candidiasis and hoarseness. “Swish and Spit” required.
ICS
Useful for patients who are poorly controlled by conventional therapy or experience A/E secondary to corticosteroids. Not monotherapy.
Leukotriene modifiers Cromolyn Chrolinergic Antagonists Theophylline Omalizumab
Alternative Asthma Treatment
Products of the 5-lipoxygenase pathway
Leukotrienes
5-lipoxygenase inhibitor
Zileuton